NCT05454956: A trial that was reported late by Tarsus Pharmaceuticals, Inc.
This trial has reported, although it was 206 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT05454956 |
|---|---|
| Title | Randomized, Double-Masked, Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of Meibomian Gland Dysfunction in Patients With Demodex Lid Infestation |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 3, 2022 |
| Completion date | May 18, 2023 |
| Required reporting date | May 17, 2024, midnight |
| Actual reporting date | Dec. 10, 2024 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 206 |